SNaPP Study published
Congratulations to Professor Leslie, Sofia Sidiropoulos and the SNaPP Study team, with results published in Lancet Respiratory Medicine.
From left to right: Prof Kate Leslie AO, Bhavita Patel, Dr Violet Mukaro, Sofia Sidiropoulos and Vi Ha.
The findings of the SNaPP Study (Sugammadex, Neostigmine and Postoperative Pulmonary complications) led by the Department of Critical Care, University of Melbourne, and the Australian and New Zealand College of Anaesthetists (ANZCA) Clinical Trials Network (CTN) were recently published in The Lancet Respiratory Medicine.
The study’s Principal Investigator, specialist anaesthetist Professor Kate Leslie AO, said the study answers one of the most hotly debated questions in anaesthesia:
“Lung complications can increase the need for oxygen after surgery and cause distress to patients. By reversing muscle relaxant drugs more effectively, sugammadex helps patients breathe more deeply and prevents collapse of lung tissue,” she said.
Professor Leslie said the trial findings highlighted a “hidden global pandemic” of lung complications for many patients after surgery.
The trial was sponsored by The University of Melbourne, with Trial Manager Sofia Sidiropoulos and her team, Dr Violet Mukaro, Bhavita Patel, and Vi Ha coordinating the trial from the Department of Critical Care. Forty-four hospitals and 3500 patients in Australia, New Zealand and Hong Kong were involved in the four-year study, which received $2.9 million from the Medical Research Future Fund (MRFF).